Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oruka Therapeutics, Inc. (ORKA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oruka Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 907654.
Total stock buying since 2015: $5,676,016.
Total stock sales since 2015: $8,480,627.
Total stock option exercises since 2015: $51,240.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 122,882 | $1,407,366 | 7,000 | $210,763 | 7,000 | $51,240 |
| 2024 | 634,678 | $2,140,999 | 0 | $0 | 160,000 | $0 |
| 2022 | 757,801 | $1,738,112 | 0 | $0 | 0 | $0 |
| 2021 | 60,000 | $145,149 | 0 | $0 | 0 | $0 |
| 2020 | 28,056 | $124,930 | 0 | $0 | 0 | $0 |
| 2018 | 0 | $0 | 14,684,808 | $7,431,777 | 0 | $0 |
| 2017 | 46,000 | $119,460 | 4,496 | $11,250 | 0 | $0 |
| 2016 | 0 | $0 | 8,493 | $26,635 | 0 | $0 |
| 2015 | 0 | $0 | 905,715 | $800,202 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-12 | 0 | $0 | 7,000 | $210,763 | 7,000 | $51,240 |
| 2025-02 | 122,882 | $1,407,366 | 0 | $0 | 0 | $0 |
| 2024-11 | 0 | $0 | 0 | $0 | 160,000 | $0 |
| 2024-08 | 5,818 | $17,180 | 0 | $0 | 0 | $0 |
| 2024-07 | 628,860 | $2,123,819 | 0 | $0 | 0 | $0 |
| 2022-05 | 354,127 | $811,309 | 0 | $0 | 0 | $0 |
| 2022-04 | 403,674 | $926,803 | 0 | $0 | 0 | $0 |
| 2021-11 | 50,000 | $113,199 | 0 | $0 | 0 | $0 |
| 2021-05 | 10,000 | $31,950 | 0 | $0 | 0 | $0 |
| 2020-12 | 10,000 | $41,630 | 0 | $0 | 0 | $0 |
| 2020-09 | 18,056 | $83,300 | 0 | $0 | 0 | $0 |
| 2018-04 | 0 | $0 | 1,596 | $796 | 0 | $0 |
| 2018-02 | 0 | $0 | 14,683,212 | $7,430,981 | 0 | $0 |
| 2017-07 | 10,000 | $24,900 | 0 | $0 | 0 | $0 |
| 2017-05 | 11,000 | $29,810 | 0 | $0 | 0 | $0 |
| 2017-04 | 0 | $0 | 2,642 | $6,421 | 0 | $0 |
| 2017-03 | 25,000 | $64,750 | 0 | $0 | 0 | $0 |
| 2017-02 | 0 | $0 | 1,854 | $4,829 | 0 | $0 |
| 2016-10 | 0 | $0 | 483 | $1,183 | 0 | $0 |
| 2016-09 | 0 | $0 | 4,347 | $12,571 | 0 | $0 |
| 2016-04 | 0 | $0 | 2,588 | $9,108 | 0 | $0 |
| 2016-03 | 0 | $0 | 915 | $3,220 | 0 | $0 |
| 2016-02 | 0 | $0 | 160 | $553 | 0 | $0 |
| 2015-10 | 0 | $0 | 496 | $2,549 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-19 | Goncalves Joana (Chief Medical Officer) | Sale | 7,000 | 30.11 | 210,763 |
| 2025-12-19 | Goncalves Joana (Chief Medical Officer) | Option Ex | 7,000 | 7.32 | 51,240 |
| 2025-02-14 | Shah Nimish P | Buy | 88,794 | 11.44 | 1,015,803 |
| 2025-02-13 | Shah Nimish P | Buy | 14,950 | 11.63 | 173,868 |
| 2025-02-12 | Shah Nimish P | Buy | 8,971 | 11.86 | 106,396 |
| 2025-02-11 | Shah Nimish P | Buy | 9,593 | 10.95 | 105,043 |
| 2025-02-10 | Shah Nimish P | Buy | 574 | 10.90 | 6,256 |
| 2024-11-19 | Harwin Peter Evan | Option Ex | 160,000 | .00 | 0 |
| 2024-08-16 | Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) | Buy | 5,818 | 2.95 | 17,180 |
| 2024-07-25 | Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) | Buy | 30,227 | 3.05 | 92,283 |
| 2024-07-24 | Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) | Buy | 189,856 | 3.18 | 603,552 |
| 2024-07-11 | Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) | Buy | 94,537 | 3.45 | 326,341 |
| 2024-07-10 | Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) | Buy | 55,463 | 3.46 | 192,123 |
| 2024-07-09 | Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) | Buy | 16,917 | 3.43 | 58,092 |
| 2024-07-08 | Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) | Buy | 47,492 | 3.47 | 164,939 |
| 2024-07-05 | Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) | Buy | 28,326 | 3.42 | 96,874 |
| 2024-07-03 | Janus Henderson Biotech Innovation Master Fund Ltd (10% Owner) | Buy | 166,042 | 3.55 | 589,615 |
| 2022-05-25 | Ma-weaver Jacob | Buy | 64,851 | 2.32 | 150,713 |
| 2022-05-24 | Ma-weaver Jacob | Buy | 18,110 | 2.29 | 41,381 |
| 2022-05-23 | Ma-weaver Jacob | Buy | 2,301 | 2.29 | 5,280 |
| 2022-05-19 | Ma-weaver Jacob | Buy | 1 | 2.25 | 2 |
| 2022-05-18 | Ma-weaver Jacob | Buy | 13,072 | 2.31 | 30,130 |
| 2022-05-16 | Ma-weaver Jacob | Buy | 42,914 | 2.30 | 98,659 |
| 2022-05-13 | Ma-weaver Jacob | Buy | 14,000 | 2.29 | 32,116 |
| 2022-05-12 | Ma-weaver Jacob | Buy | 27,922 | 2.27 | 63,382 |
| 2022-05-11 | Ma-weaver Jacob | Buy | 24,596 | 2.29 | 56,201 |
| 2022-05-10 | Ma-weaver Jacob | Buy | 20,979 | 2.29 | 47,937 |
| 2022-05-09 | Ma-weaver Jacob | Buy | 49,221 | 2.27 | 111,731 |
| 2022-05-06 | Ma-weaver Jacob | Buy | 57,998 | 2.28 | 132,409 |
| 2022-05-05 | Ma-weaver Jacob | Buy | 16,903 | 2.27 | 38,454 |
| 2022-05-02 | Ma-weaver Jacob | Buy | 1,259 | 2.31 | 2,914 |
| 2022-04-29 | Ma-weaver Jacob | Buy | 8,974 | 2.30 | 20,640 |
| 2022-04-28 | Ma-weaver Jacob | Buy | 23,381 | 2.32 | 54,173 |
| 2022-04-25 | Ma-weaver Jacob | Buy | 13,751 | 2.29 | 31,503 |
| 2022-04-18 | Ma-weaver Jacob | Buy | 9,119 | 2.31 | 21,083 |
| 2022-04-14 | Ma-weaver Jacob | Buy | 17,410 | 2.33 | 40,547 |
| 2022-04-12 | Ma-weaver Jacob | Buy | 69,398 | 2.32 | 161,072 |
| 2022-04-11 | Ma-weaver Jacob | Buy | 4,655 | 2.31 | 10,776 |
| 2022-04-08 | Ma-weaver Jacob | Buy | 30,660 | 2.31 | 70,855 |
| 2022-04-07 | Ma-weaver Jacob | Buy | 27,450 | 2.32 | 63,711 |
| 2022-04-06 | Ma-weaver Jacob | Buy | 26,806 | 2.30 | 61,600 |
| 2022-04-05 | Ma-weaver Jacob | Buy | 49,728 | 2.30 | 114,473 |
| 2022-04-04 | Funicular Fund, Lp | Buy | 122,342 | 2.26 | 276,370 |
| 2021-11-22 | Ozeroff Christopher David (S.V.P., General Counsel) | Buy | 50,000 | 2.26 | 113,199 |
| 2021-05-12 | Conway Robert E (Director) | Buy | 10,000 | 3.19 | 31,950 |
| 2020-12-18 | Conway Robert E (Director) | Buy | 10,000 | 4.16 | 41,630 |
| 2020-09-25 | Conway Robert E (Director) | Buy | 5,000 | 4.28 | 21,400 |
| 2020-09-22 | Conway Robert E (Director) | Buy | 3,056 | 4.66 | 14,240 |
| 2020-09-21 | Conway Robert E (Director) | Buy | 10,000 | 4.77 | 47,660 |
| 2018-04-03 | Keuer Thomas A (Chief Operating Officer) | Sale | 482 | .50 | 241 |
| 2018-04-02 | Selby Brian L. (VP, Finance) | Sale | 1,114 | .50 | 555 |
| 2018-02-27 | Shah Nimish P (10% Owner) | Sale | 41,331 | .53 | 21,905 |
| 2018-02-26 | Shah Nimish P (10% Owner) | Sale | 1,500,000 | .55 | 825,000 |
| 2018-02-26 | Nea 15 Gp, Llc (10% Owner) | Sale | 1,460,209 | .50 | 731,564 |
| 2018-02-26 | Sakoda Jon (10% Owner) | Sale | 1,460,209 | .50 | 731,564 |
| 2018-02-26 | Florence Anthony A. Jr. (10% Owner) | Sale | 1,460,209 | .50 | 731,564 |
| 2018-02-26 | Sonsini Peter W. (10% Owner) | Sale | 1,460,209 | .50 | 731,564 |
| 2018-02-26 | Baskett Forest (10% Owner) | Sale | 1,460,209 | .50 | 731,564 |
| 2018-02-26 | Sandell Scott D (10% Owner) | Sale | 1,460,209 | .50 | 731,564 |
| 2018-02-26 | Makower Joshua (10% Owner) | Sale | 1,460,209 | .50 | 731,564 |
| 2018-02-26 | Mott David M (10% Owner) | Sale | 1,460,209 | .50 | 731,564 |
| 2018-02-26 | Barris Peter J (10% Owner) | Sale | 1,460,209 | .50 | 731,564 |
| 2017-07-14 | Conway Robert E (Director) | Buy | 10,000 | 2.49 | 24,900 |
| 2017-05-02 | Mitchell Daniel J (Director) | Buy | 11,000 | 2.71 | 29,810 |
| 2017-04-04 | Ozeroff Christopher David (S.V.P., General Counsel) | Sale | 418 | 2.41 | 1,007 |
| 2017-04-04 | Keuer Thomas A (Chief Operating Officer) | Sale | 390 | 2.41 | 939 |
| 2017-04-04 | Bristow Michael R (Pres. & Chief Executive Offic) | Sale | 720 | 2.41 | 1,735 |
| 2017-04-03 | Selby Brian L. (VP, Finance) | Sale | 1,114 | 2.46 | 2,740 |
| 2017-03-24 | Conway Robert E (Director) | Buy | 25,000 | 2.59 | 64,750 |
| 2017-02-28 | Ozeroff Christopher David (S.V.P., General Counsel) | Sale | 465 | 2.61 | 1,213 |
| 2017-02-28 | Keuer Thomas A (Chief Operating Officer) | Sale | 465 | 2.61 | 1,213 |
| 2017-02-28 | Bristow Michael R (Pres. & Chief Executive Offic) | Sale | 763 | 2.61 | 1,991 |
| 2017-02-27 | Selby Brian L. (VP, Finance) | Sale | 161 | 2.56 | 412 |
| 2016-10-18 | Keuer Thomas A (Chief Operating Officer) | Sale | 483 | 2.45 | 1,183 |
| 2016-09-20 | Ozeroff Christopher David (S.V.P., General Counsel) | Sale | 1,185 | 2.89 | 3,424 |
| 2016-09-20 | Keuer Thomas A (Chief Operating Officer) | Sale | 714 | 2.89 | 2,063 |
| 2016-09-20 | Bristow Michael R (Pres. & Chief Executive Offic) | Sale | 1,972 | 2.89 | 5,699 |
| 2016-09-19 | Selby Brian L. (VP, Finance) | Sale | 476 | 2.91 | 1,385 |
| 2016-04-05 | Ozeroff Christopher David (S.V.P., General Counsel) | Sale | 366 | 3.52 | 1,288 |
| 2016-04-05 | Keuer Thomas A (Chief Operating Officer) | Sale | 384 | 3.52 | 1,351 |
| 2016-04-05 | Bristow Michael R (See Remarks) | Sale | 724 | 3.52 | 2,548 |
| 2016-04-04 | Selby Brian L. (VP, Finance) | Sale | 1,114 | 3.52 | 3,921 |
| 2016-03-01 | Ozeroff Christopher David (S.V.P., General Counsel) | Sale | 458 | 3.51 | 1,607 |
| 2016-03-01 | Keuer Thomas A (Chief Operating Officer) | Sale | 457 | 3.53 | 1,613 |
| 2016-02-29 | Selby Brian L. (VP, Finance) | Sale | 160 | 3.46 | 553 |
| 2015-10-16 | Keuer Thomas A (Chief Operating Officer) | Sale | 496 | 5.14 | 2,549 |
| 2015-09-18 | Selby Brian L. (VP, Finance) | Sale | 476 | 6.23 | 2,965 |
| 2015-09-18 | Ozeroff Christopher David (S.V.P., General Counsel) | Sale | 1,129 | 6.32 | 7,135 |
| 2015-09-18 | Keuer Thomas A (Chief Operating Officer) | Sale | 680 | 6.33 | 4,304 |
| 2015-09-18 | Bristow Michael R (See Remarks) | Sale | 1,809 | 6.33 | 11,450 |
| 2015-03-02 | Selby Brian L. (VP, Finance) | Sale | 1,125 | .71 | 799 |
| 2015-01-16 | Mccormack Riley (10% Owner) | Sale | 100,000 | .75 | 75,000 |
| 2015-01-15 | Mccormack Riley (10% Owner) | Sale | 125,000 | .75 | 93,750 |
| 2015-01-14 | Mccormack Riley (10% Owner) | Sale | 125,000 | .79 | 98,750 |
| 2015-01-07 | Mccormack Riley (10% Owner) | Sale | 200,000 | .87 | 174,000 |
| 2015-01-06 | Mccormack Riley (10% Owner) | Sale | 200,000 | .92 | 184,000 |
| 2015-01-05 | Mccormack Riley (10% Owner) | Sale | 150,000 | .97 | 145,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of ORKA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oruka Therapeutics, Inc. (symbol ORKA, CIK number 907654) see the Securities and Exchange Commission (SEC) website.